Shared on 05 Sep 25
Expanding Biosimilars And CDMO Will Open Global Markets
As both revenue growth and net profit margin forecasts for Alkem Laboratories remain stable, analysts have maintained their consensus price target at ₹5535. What's in the News Launched Olesoft Trucera, an advanced prescription moisturizing lotion, expanding its Olesoft range, which is already the most prescribed by dermatologists in India.
Shared on 01 May 25
Fair value Increased 1.93%Expanding Biosimilars And CDMO Will Open Global Markets
Shared on 23 Apr 25
Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 5.00%Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 5.09%Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
Shared on 02 Apr 25
Fair value Increased 1.69%Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 3.29%Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position
AnalystConsensusTarget has decreased future PE multiple from 35.5x to 31.8x.